Product Information(Japanese)
Contact Us
for Business Opportunity
2012.05.15
Onconova Advances Oral Rigosertib to Phase II Clinical Trial in Myelodysplastic Syndromes
2012.05.11
Financial Results for the First Quarter of Fiscal Year Ended December 31, 2012 [Japan GAAP] (Non-consolidated)
2012.04.16
SymBio Announces Presentation at BioCentury Future Leaders in the Biotech Industry Conference
2012.03.29
Clinical Trial Notificaation Accepted for SymBio's Japan Phase 1 Trial of Rigosertib(SyB L-1101) in Refractory/Relapsed MDS
Product Information(Japanese)
Contact Us